Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Genes and Longevity—Can One Base Pair Make a Difference?
14 April 2003. In this month's Journal of Medical Genetics, a group of Italian researchers propose that there is a link between longevity and a single nucleotide polymorphism (SNP) in the promoter for the antiinflammatory cytokine interleukin-10 (IL-10). This may be particularly relevant to researchers of Alzheimer's and Parkinson's diseases, and other neurologic disorders that are age-related and exacerbated by inflammatory processes.

First author Domenico Lio and colleagues, working with Calogero Caruso at the University of Palermo, Italy, made the link after analyzing DNA samples from 174 centenarians and 227 nonrelated, geographically matched controls aged 22 to 60 years. Lio and colleagues found that centenarian men (n=72) more frequently had a guanosine base in position -1082 of the IL-10 gene, in contrast to the adenine that predominates in control subjects, but also, curiously, in centenarian women. The finding is statistically significant—46 percent of centenarian men vs. only 28 percent of controls had guanosine at this position in both copies of the gene. It is unknown, naturally, who among the control group will also live to see their one hundredth birthday. The authors did not report any SNP analysis of postmortem samples taken from people who died young, which could help strengthen the correlation between longevity and the SNP.

In-vitro data indicates that this adenine-to-guanosine transition in the promoter leads to greater expression of IL-10. Together, these findings lead the authors to speculate that the "antiinflammatory genotype may be highly advantageous in the last decades of life, owing to the chronic proinflammatory status, which develops in all the subjects with age." The authors also offer this "inflamm-ageing," as they call it, which is more evident in men, as an explanation for the sex difference in the SNP frequency.

Lio and colleagues also carried out SNP analysis on the tumor necrosis factor-α (TNF-α) promoter, where a similar A-to-G transition has been identified 308 base pairs upstream of the transcription start site, but found no correlation between this SNP and longevity.

The authors caution that their study has limitations, not least being that all the DNA samples were from Italian donors, so extrapolating these findings to other ethnic groups may be impossible. In Finland, for example, the frequency of the IL-10 SNP was found to be similar in nonagenarians and the rest of the population.—Tom Fagan.

Reference:
Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha-308 promoter SNP. J. Med. Genet. 2003;40:296-299. Abstract

 
Comments on News and Primary Papers
  Comment by:  Tadeusz Pietras
Submitted 14 April 2003  |  Permalink Posted 14 April 2003
  I recommend the Primary Papers
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad